These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 28652021)

  • 21. Detection of circulating urothelial cancer cells in the blood using the CellSearch System.
    Naoe M; Ogawa Y; Morita J; Omori K; Takeshita K; Shichijyo T; Okumura T; Igarashi A; Yanaihara A; Iwamoto S; Fukagai T; Miyazaki A; Yoshida H
    Cancer; 2007 Apr; 109(7):1439-45. PubMed ID: 17326057
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Flow Cytometric Detection of Circulating Osteosarcoma Cells in Dogs.
    Wright T; Brisson BA; Wood GA; Oblak M; Mutsaers AJ; Sabine V; Skowronski K; Belanger C; Tiessen A; Bienzle D
    Cytometry A; 2019 Sep; 95(9):997-1007. PubMed ID: 31282052
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel method for downstream characterization of breast cancer circulating tumor cells following CellSearch isolation.
    Frithiof H; Welinder C; Larsson AM; Rydén L; Aaltonen K
    J Transl Med; 2015 Apr; 13():126. PubMed ID: 25896421
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An immunomagnetic epithelial tumor cell enrichment model for minimal residual disease detection of cytokeratin 8+ malignancies.
    Brooimans RA; de Leeuw N; Bontenbal M; Gratama JW
    J Biol Regul Homeost Agents; 2005; 19(1-2):84-91. PubMed ID: 16178280
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biotin-triggered decomposable immunomagnetic beads for capture and release of circulating tumor cells.
    Lu NN; Xie M; Wang J; Lv SW; Yi JS; Dong WG; Huang WH
    ACS Appl Mater Interfaces; 2015 Apr; 7(16):8817-26. PubMed ID: 25853336
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Detection and clinical significance of circulating tumor cells in peripheral blood of breast cancer patients].
    Cai QQ; Huang HQ; Lin TX; Jiang WQ
    Ai Zheng; 2005 Jul; 24(7):837-41. PubMed ID: 16004811
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epithelial-mesenchymal transitioned circulating tumor cells capture for detecting tumor progression.
    Satelli A; Mitra A; Brownlee Z; Xia X; Bellister S; Overman MJ; Kopetz S; Ellis LM; Meng QH; Li S
    Clin Cancer Res; 2015 Feb; 21(4):899-906. PubMed ID: 25516888
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multi-Marker Immunomagnetic Enrichment of Circulating Melanoma Cells.
    Beasley AB; Acheampong E; Lin W; Gray ES
    Methods Mol Biol; 2021; 2265():213-222. PubMed ID: 33704717
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Identification of circulating tumor cells as a promising method of genitourinary cancer diagnosis].
    Gurtowska N; Bajek A; Olkowska J; Drewa T
    Postepy Hig Med Dosw (Online); 2012 Dec; 66():983-90. PubMed ID: 23687217
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sensitive antibody-based CTCs detection from peripheral blood.
    Shahneh FZ
    Hum Antibodies; 2013; 22(1-2):51-4. PubMed ID: 24284308
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analytical evaluation for somatic mutation detection in circulating tumor cells isolated using a lateral magnetophoretic microseparator.
    Cho H; Kim J; Han SI; Han KH
    Biomed Microdevices; 2016 Oct; 18(5):91. PubMed ID: 27628059
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Integrative diagnosis of cancer by combining CTCs and associated peripheral blood cells in liquid biopsy.
    Zhang WW; Rong Y; Liu Q; Luo CL; Zhang Y; Wang FB
    Clin Transl Oncol; 2019 Jul; 21(7):828-835. PubMed ID: 30569214
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of a Novel c-MET-Based CTC Detection Platform.
    Zhang T; Boominathan R; Foulk B; Rao C; Kemeny G; Strickler JH; Abbruzzese JL; Harrison MR; Hsu DS; Healy P; Li J; Pi C; Prendergast KM; Hobbs C; Gemberling S; George DJ; Hurwitz HI; Connelly M; Garcia-Blanco MA; Armstrong AJ
    Mol Cancer Res; 2016 Jun; 14(6):539-47. PubMed ID: 26951228
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Label-Free Enrichment and Molecular Characterization of Viable Circulating Tumor Cells from Diagnostic Leukapheresis Products.
    Franken A; Driemel C; Behrens B; Meier-Stiegen F; Endris V; Stenzinger A; Niederacher D; Fischer JC; Stoecklein NH; Ruckhaeberle E; Fehm T; Neubauer H
    Clin Chem; 2019 Apr; 65(4):549-558. PubMed ID: 30737205
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Feasibility of a novel one-stop ISET device to capture CTCs and its clinical application.
    Chen F; Wang S; Fang Y; Zheng L; Zhi X; Cheng B; Chen Y; Zhang C; Shi D; Song H; Cai C; Zhou P; Xiong B
    Oncotarget; 2017 Jan; 8(2):3029-3041. PubMed ID: 27935872
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Filtration based assessment of CTCs and CellSearch® based assessment are both powerful predictors of prognosis for metastatic breast cancer patients.
    Huebner H; Fasching PA; Gumbrecht W; Jud S; Rauh C; Matzas M; Paulicka P; Friedrich K; Lux MP; Volz B; Gass P; Häberle L; Meier-Stiegen F; Hartkopf A; Neubauer H; Almstedt K; Beckmann MW; Fehm TN; Ruebner M
    BMC Cancer; 2018 Feb; 18(1):204. PubMed ID: 29463222
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of DNA damage by the comet assay in fresh versus cryopreserved peripheral blood mononuclear cells obtained following dietary intervention.
    Del Bo' C; Fracassetti D; Lanti C; Porrini M; Riso P
    Mutagenesis; 2015 Jan; 30(1):29-35. PubMed ID: 25527725
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Classification of circulating tumor cells by epithelial-mesenchymal transition markers.
    Wu S; Liu S; Liu Z; Huang J; Pu X; Li J; Yang D; Deng H; Yang N; Xu J
    PLoS One; 2015; 10(4):e0123976. PubMed ID: 25909322
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Leukocyte-Repelling Biomimetic Immunomagnetic Nanoplatform for High-Performance Circulating Tumor Cells Isolation.
    Zhou X; Luo B; Kang K; Zhang Y; Jiang P; Lan F; Yi Q; Wu Y
    Small; 2019 Apr; 15(17):e1900558. PubMed ID: 30932344
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of assay methods for detection of circulating tumor cells in metastatic breast cancer: AdnaGen AdnaTest BreastCancer Select/Detect™ versus Veridex CellSearch™ system.
    Andreopoulou E; Yang LY; Rangel KM; Reuben JM; Hsu L; Krishnamurthy S; Valero V; Fritsche HA; Cristofanilli M
    Int J Cancer; 2012 Apr; 130(7):1590-7. PubMed ID: 21469140
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.